CAS Innovations Program I
(CASIP)

A planned investment vehicle of an inaugural venture incubation program by CAS lnnovations a.s. (CASI) designed to transform scientific breakthroughs from the Czech Academy of Sciences (CAS) into incubated investment-ready spin-offs.

CASI selects 8-10 projects from an active pipeline and provides them with targeted support across team formation, IP strategy, product development, product-market validation, regulatory and go-to-market planning, and investor readiness.

With dedicated capital, hands-on venture-building, and access to industry, academic, and venture capital networks, the program systematically prepares each project to launch as a credible spinout.

Portfolio Preview

CAS lnnovations Program I, which we plan to run from June 2026 to June 2027, features 8-10 breakthrough projects from CAS institutes, targeting deep tech and life sciences. Highlights are shown below.

Examples of projects in portfolio

Deep Tech

Etalons for High-Tech Microscopy

Calibration standards
(OEM manufacturing)

Deep Tech

Solar Panel Failure Detection

Solar cell defect analysis

HW/SW

Deep Tech

Coagulation Technology for Water Treatment

High-performance

coagulation agent

Deep Tech

Photostable Fluorophore

Fluoroscence-based biomedical detection

Life Sciences

New Generation Antiserums

Antisera for snakebite

treatment

Life Sciences

Organometallic Galection Inhibitor
for Breast Cancer

Therapy for triple-negative breast cancer

Life Sciences

Perfusion Imaging Software for Oncology

SW for radiological cancer diagnostics

Life Sciences

Waterjets for Plastic Surgery

Surgical tool for plastic surgery

Disclaimer

This communication does not constitute an offer to invest or a solicitation of any investment activity. It is provided solely for the purpose of market testing and is directed exclusively at qualified investors.

Any information presented is preliminary and subject to change. Participation in any future investment opportunity will be subject to formal documentation and applicable regulatory requirements.